Patent Reform Act of 2006

Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patent Reform Orphan works S. 3818 Patent Reform - discussions based on this bill H.R. 1908; S. 1145 patent reform

Client expense: $80,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT)

Intellectual Property, Patent Reform (S 3818 & HR 1908), Follow-on Biologics (S 1695), Compulsory Licensing, Counterfeiting

Client expense: $1,960,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, H.R. 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2795, Patent Act of 2005. S. Res. 142, Resolution that US Trade Rep. should bring WTO case against China. S 3818, Patent Reform Act of 2006.

Client expense: $20,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), UNDETERMINED

Issues related to draft legislation concerning asset forfeiture, Issues related to Digital Millennium Copyright Act, Issues related to Patent Litigation Reform, HR 2795 Patent Act of 2005, S. 3818 Patent Reform Act of 2006, HR 5096 Patent Depend on Quality Act of 2006, HR 5418 U.S. District Court Patent Pilot Program

Client expense: $890,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

HR 2795, Patent Act of 2005 S 3818, Patent Reform Act of 2006 Patent Reform

Client expense: $730,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2795, Patent Reform Act of 2005 S.3818, Patent Reform Act of 2006 H.R. 5418 H.R 5096, Patents Depend on Quality Act of 2006

Client expense: $300,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

S. 3818 - Patent Reform Acto of 2006, provisons related to patent protection

Client expense: $700,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

Client expense: $5,800,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Intellectual Property Patent Reform (S3818)

Client expense: $1,900,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Patent Reform (S. 3818, S. 2109, H.R. 2795)

Client expense: $440,000 · Firm income: Not reported

Government targets: Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, HOUSE OF REPRESENTATIVES, Office of the Comptroller of the Currency (OCC), SENATE, Small Business Administration (SBA)

Patent Reform Act (S. 3818 & HR 2795)

Client expense: Not reported · Firm income: $30,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

S. 3818, Patent Reform Act of 2006 Orphan Works, Patent Litigation Reform and Copyright Reform, Including: H.R. 5439, Orphan Works Act of 2006 H.R. 2795, Patent Reform Act of 2005 H.R. 5553, Section 115 Reform Act of 2006

Client expense: $780,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), SENATE

H.R.2795, Patent Act of 2005 Process Patents Patent Reform S 3818, Patent Act of 2006

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2795, Patent Act of 2005 Intellectual Property and Process Patent Issues S 3818, Patent Reform Act of 2006

Client expense: Not reported · Firm income: $300,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2795, Patent Act of 2005 Patent Reform S 3818, Patent Act of 2006

Client expense: Not reported · Firm income: $60,000

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC)

federal drug approval process for generic drugs and appropriated funding (H.R. 376); revision of BioShield provisions of S.3; development of a biogeneric drug approval framework; procedures for drug approval harmonization in prospective trade agreements; implementation of the Medicare Prescription Drug improvement and Modernization Act of 2003 (P.L. 108-391). Issues affecting pharmaeuticals, including: Settlements legislation, S.3582; opposition to legislation proposing patent filing deadline extensions; authorized generics (H.R. 5384); patent reform legislation (H.R. 2795 and S.3818); FDA reform and regulation, and the

Client expense: Not reported · Firm income: $100,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2795, Patent Reform Act of 2005; H.R. 5418, Trademark Dilution legislation and criminal intellectual property legsilation; S. 3818, Patent Reform Act of 2006.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Intellectual Property and Process Patent Issues H.R. 2795: Patent Act of 2005 S. 3818: Patent Reform Act of 2006

Client expense: $5,620,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

Client expense: $7,720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S3818:PATENT REFORM ACT; ALL ASPECTS OF BILL

Client expense: Not reported · Firm income: $60,000

Government targets: SENATE

H.R.2795-Patent Reform Act of 2005-re reforms to the patent system. S.3818-Patent Reform Act of 2006-re reforms to the patent system.

Client expense: $1,380,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S2113: ESTABLISH WIDESPREAD AVAILABILITY OF TELECOMMUNICATIONS NETWORK DEVICES; FAIR PRACTICE FOR INTERNET ACCESS SECTION S758: INTERNET TAX NONDISCRIMINATION ACT; BAN OF INTERNET TAXATION HR4569: DIGITAL TRANSITION CONTENT SECURITY ACT: AUDIO HOLE PROVISIONS HR4861: AUDIO BROADCAST FLAG LICENSING ACT: AUDIO FLAG PROVISIONS HR5417: INTERNET FREEDOM & NON-DISCRIMINATION ACT: NET NEUTRALITY PROVISIONS S2686: COMMUNICATIONS, CONSUMER'S CHOICE BROADBAND DEPLOYMENT ACT OF 2006; NET NEUTRALITY PROVISIONS S3818: PATENT REFORM ACT: PATENT LITIGATION S1504: MARKET DRIVEN TELECOMMUNICATIONS MARKETPLACE; NET NEUTRALITY ISSUES HR2354: TV CONSUMER CHOICE ACT; EFFECT ON DTV TRANSITION HR1201: DIGITAL RIGHTS CONSUMER'S ACT; FAIR USE DEFINITION

Client expense: $600,000 · Firm income: Not reported

Government targets: Education, Dept of, Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE

World Health Organization Access to Medicines CBD TRIPS Amendment Genetic Origin Disclosure Requirements Patent Courts H.R. 5418 PTO Proposed Regulations Continuation Applications: 37 CFR Part 1 Information Disclosures Rules : 71 FR 38808 Claims Rules Intellectual Property Aspects of US Malaysia Free Trade Agreement Genetic Origin Disclosure Requirements Patenting of Plants and Animals Intellectual Property Aspects of US Korea Free Trade Agreement Data Exclusivity Patent Linkage Patent Reform S. 3818: Patent Reform Act of 2006

Client expense: $2,860,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, H.R. 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, H.R. 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, H.R. 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR2795/S3818: PATENT REFORM ACT OF 2005: ALL PROVISIONS OF THE BILL

Client expense: $680,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Education, Dept of, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

S. 1785, the Vessel Hull Design Protection Act of 2005 H.R. 4131, the Public Health Emergency Medicines Act (Compulsory licensing of patented drugs). H.R. 683, the Trademark Dilution Revision Act of 2005 H.R. 2791, the United States Patent and Trademark Fee Modernization Act of 2005 H.R. 2795, the Patent Reform Act of 2005 H.R. 2955, the Intellectual Property Jurisdiction Clarification Act of 2005 H.R. 4742, Waiver of Patent and Trademark Requirements during Emergencies H.R. 5055, the Design Piracy Prohibition Act H. R. 5096, the Patents Depend on Quality Act of 2006 (Patent law reform.) H.R. 4569, the Digital Content Security Protection Act of 2005 H.R. 5439, the Orphan Works Act of 2006 (Legal protection for fashion design.) H.R. 5553, the Section 115 Reform Act (Patent law reform.) H.R. 3175, the Life-Saving Medicines Export Act of 2006 (Compulsory licensing of patented drugs in health emergencies) H.R. 5418, a bill to establish a pilot program for patents cases in U.S. district courts. S. 3818, the Patent Reform Act of 2006 (Patent law reform.) H.R. 5921, the Intellectual Property Enhanced Criminal Enforcement Act of 2006 H.R. 5553, the Section 115 Reform Act (Copyright licensing of digital delivery of music works)

Client expense: $560,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Commission on Civil Rights, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

Patent Reform H.R. 2795 Patent Reform Act of 2005 H.R. 5096 Patents Depend on Quality Act of 2006 Post-Patent-Grant Review Venue Damages Apportionment Enhanced Damages Fee Shifting Third Party Submission of Prior Act with Commentary Patent Claim Clarity Patent Quality H.R. 5672 Science, Justice, Commerce, and Related Agencies Appropriations Act, 2007 H.R. 5631/H.J. Res 100/H.J. Res 102 Continuing Appropriations Resolution, FY 2007 Patent and Trademark Office Funding H.R. 5418/S. 3923 Legislation to establish a pilot program to enhance judicial patent expertise in certain U.S. district courts H.R. 2955 Intellectual Property Jurisdiction Clarification Act of 2005 Community Patent Review Analog Hole H.R. 4569 Digital Transition Content Security Act of 2005 S. 2686 Communications, Consumer's Choice, and Broadband Deployment Act of 2006 Broadcast Flag Open Source Software APEC Technology Choice Principles OECD Proposal on Innovation and Competition in the Software Sector Japan OECD Proposal on Software Open Standards and Interoperability S. 3818 Patent Reform Act of 2006 "Ex Ante" Disclosure of IP in standard-setting

Client expense: $3,700,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Council of Economic Advisers (CEA), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Technology Administration, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

H.R. 2795, Patent Reform Act of 2005 S.3818, Patent Reform Act of 2006 H.R. 5418 H.R 5096, Patents Depend on Quality Act of 2006

Client expense: $300,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

HR 2795 Patent Reform Act - Injunctive Relief S 3818 Patent Reform Act of 2006

Client expense: $600,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), White House Office

HR.2795, Patent Reform Act of 2005 HR.32, Stop Counterfeiting Manufactured Good S.3818, Patent Reform Act of 2005 Revision of current penalities for IP infringement

Client expense: $939,407 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 2795, Patent Reform Act of 2005; S. 3818, Patent Reform Act of 2006.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2795, Patent Act of 2005; S. 3818, Patent Reform Act of 2006; H.R. 683, Trademark Dilution Revision Act of 2005; WIPO Broadcasting Treaty; DOJ Criminal IP legislation; H.R. 5553, Section 115 Reform Act of 2006; H.R. 5055, Design Piracy Prohibition Act

Client expense: Not reported · Firm income: $100,000

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE

S. 3818, Patent Reform Act of 2006; H.R. 2795, Patent Act of 2005; H.R. 4127, Data Accountability and Trust Act (DATA); H.R. 5418

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2795, Patent Reform Act of 2005 HR 2791, United States Patent and Trademark Fee Modernization Act of 2005 S 3818, Patent Reform Act HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges. H.R. 4569, Digital Transition Content Security Act of 2005 H.R. 32, Stop Counterfeiting in Manufactured Goods Act S 2686, Communications, Consumer's Choice, and Broadband Deployment Act of 2006 H.R. 1201, Digital Media Consumers' Rights Act of 2005 H.R. 683, Trademark Dilution Revision Act of 2006 H.R. 1036, Copyright Royalty Judges Program Technical Corrections Act H.R. 5439, Orphan Works Act of 2006 H.R. 5553, Section 115 Reform Act of 2006

Client expense: $1,820,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

HR 2795, Patent Act of 2005 S 3818, Patent Reform Act of 2006 Patent Reform

Client expense: Not reported · Firm income: $100,000

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Funding of the US Patent & Trademark Office, Patent Fees, H.R.2791; copy protection mandates on technology products, H.R.4569; copyright enforcement; patent policies in standards development, H.R.1932, from 1082 Conf.; FCC rulemaking on the broadcast flag, plug & play, S.2686; counterfeiting, H.R.32; patent reform legislation, H.R.2795, S.3818; H.R.5418; H.R.4861; S.2686/H.R.5252; patent court pilot program, H.R.5418.

Client expense: $440,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade & Development Agency (USTDA), U.S. Trade Representative (USTR), White House Office

S. 3818, the Patent Reform Act of 2006

Client expense: $102,200 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S 3582, Preserve Access to Affordable Generics Act, patent issues HR 2795, Patent Reform Act of 2005, patent issues HR 5416, pilot program on patent cases S 2300, Lower Priced Drugs Act, patent issues S 3818, Patent Reform Act of 2006, patent issues

Client expense: $8,840,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S. 3818 - Patent Reform Acto of 2006, provisons related to patent protection

Client expense: $700,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patent Reform: S. 3818, Patent Reform Act of 2006.

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office